Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Effect of posture and sleep on pharmacokinetics

I. Amoxycillin

Summary

The pharmacokinetics of amoxycillin in normal male volunteers was studied during the states of bedrest, sleep and ambulation. The absorption and disposition of amoxycillin in ambulatory subjects was found to be comparable to that reported previously by other workers. Serum amoxycillin concentrations were found to be significantly greater during ambulation than during bedrest and sleep. The difference in serum levels resulted from an increased apparent total serum clearance and amoxycillin renal clearance during bedrest and sleep compared to ambulation. No significant differences in the clearance was found between the states of bedrest and sleep. The change in renal clearance of amoxycillin during ambulation was attributed to a diminished renal blood flow. Although the terminal half-life of amoxycillin did not differ significantly, the apparent volume of distribution appears to be much greater during bedrest and sleep than during ambulation. This difference could be explained pharmacokinetically using a two compartment model. No significant difference was found between the rates of absorption of amoxycillin as reflected by the lag time and time to peak serum amoxycillin. The actual values for these parameters would suggest, however, that the absorption of amoxycillin is faster during ambulation than in bedrest and that the absorption rate during sleep is slowest. The clinical implications of the effect of posture and sleep on the pharmacokinetics of amoxycillin are discussed.

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Adir J, Barr WH (1977) Effect of sleep on bioavailability of tetracycline. J Pharm Sci 66: 1000–1004

  2. Beckett AH, Rowland M (1964) Rhythmic urinary excretion of amphetamine in man. Nature (London) 204: 1203–1204

  3. Craig WA, Welling PG (1977) Protein binding of antimicrobials: Clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet 2: 252–268

  4. Davidson DF (1976) A simple chemical method for the assay of amoxycillin in serum and urine. Clin Chim Acta 69: 67–71

  5. Dettli L, Spring P (1966) Diurnal variations in the elimination rate of a sulphonamide in man. Helv Med Acta 33: 291–306

  6. Elfström J, Lindgren S (1978) Effect of bedrest on the pharmacokinetics of phenazone. Eur J Clin Pharmacol 13: 379–383

  7. Eshelman FN, Spyker DA (1978) Pharmacokinetics of amoxycillin and ampicillin: Crossover study of the effect of food. Antimicrob Agents Chemother 14: 539–543

  8. Gibaldi M (1977) Biopharmaceutics and clinical pharmacokinetics, Chap. 6. Lea and Febiger, Philadelphia

  9. Gibaldi M, Perrier D (1972) Drug elimination and apparent volumes of distribution in multicompartmental systems. J Pharm Sci 61: 952–954

  10. Gibaldi M, Perrier D (1975) Pharmacokinetics, Chaps. 2, 4, 5. Marcel Dekker Inc, New York

  11. Goldstein A (1964) Biostatistics: An introductory text, Chap. 2. The Macmillan Co., New York

  12. Krüger-Thiemer E (1977) Pharmacokinetics: Kinetic aspects of absorption, distribution and elimination of drugs. In: Van Rossum JM (ed) Kinetics of drug action. Springer, Berlin Heidelberg New York, pp 63–123

  13. Levy G (1967) Effect of bedrest on distribution and elimination of drugs. J Pharm Sci 56: 928–929

  14. Nakano S, Hollister LE (1978) No circadian effect on nortriptyline kinetics in man. Clin Pharmacol Ther 23: 199–203

  15. Niebergall PJ, Sugita ET, Schnaare RL (1974) Potential dangers of common drug dosing regimens. Am J Hosp Pharm 31: 53–58

  16. Øie S, Jung D (1979) Bioavailability under variable renal clearance conditions. J Pharm Sci 68: 128–129

  17. Patel IH, Levy RH, Lockard JS (1977) Time-dependent kinetics II: Diurnal oscillations in steady-state plasma ethosuximide levels in rhesus monkeys. J Pharm Sci 66: 650–653

  18. Radigan LR, Robinson S (1949) Effects of environmental heat stress and exercise on renal blood flow and filtration rate. J Appl Physiol 2: 185–191

  19. Reinberg A (1978) Clinical chronopharmacology, an experimental basis for chronotherapy. Arzneim-Forsch 28: 1861–1867

  20. Riches HRC (1954) Streptomycin reactions — relation to exercise. Lancet 1: 540–541

  21. Ronfeld RA, Benet LZ (1971) Interpretation of plasma concentration-time curves after oral dosing. J Pharm Sci 66: 178–180

  22. Rossi L, Madsen BW (1978) Effect of sleep on Michaelis-Menten elimination of ethanol, Abstract 36. 12th Annual Meeting of the Australasian Society of Clinical and Experimental Pharmacologists, Monash University December 1978

  23. Rowland M (1973) Effect of some physiologic factors on bioavailability of oral dosage forms. In: Swarbrick J (ed) Current concepts in the pharmaceutical sciences — dosage form design and bioavailability. Lea and Febiger, Philadelphia, pp 181–222

  24. Schmidt H, Roholt K (1966) Penicillin serum concentrations in relation to exercise. Acta Pathol Microbiol Scand 68: 396–400

  25. Selkurt EE (1963) The renal circulation. In: Handbook of physiology section 2, Circulation, vol. 2. Williams and Williams, Baltimore, pp 1457–1507

  26. Shively CA, Vesell ES (1975) Temporal variations in acetaminophen and phenacetin half-life in man. Clin Pharmacol Ther 18: 413–424

  27. Sirota JH, Baldwin DS, Villarreal H (1950) Diurnal variations of renal function in man. J Clin Invest 29: 187–192

  28. Spyker DA, Rugloski RJ, Vann RL, O'Brien WM (1977) Pharmacokinetics of amoxycillin: Dose dependence after intravenous, oral and intramuscular administration. Antimicrob Agents Chemother 11: 132–141

  29. Sutherland R, Croydon EAP, Rolinson GN (1972) Amoxycillin: A new semi-synthetic penicillin. Brit Med J 3: 13–16

  30. Swartz RD, Sidell FR (1973) Effects of heat and exercise on the elimination of pralidoxime in man. Clin Pharmacol Ther 14: 83–89

  31. Swartz RD, Sidell FR, Cucinell SA (1974) Effects of physical stress on the disposition of drugs eliminated by the liver in man. J Pharmacol Exp Ther 188: 1–7

  32. Tsuji A, Nakashima E, Hamano S, Yamana T (1978) Physicochemical properties of amphoteric B-lactam antibiotics 1: Stability, solubility and dissolution behaviour of amino penicillins as a function of pH. J Pharm Sci 67: 1059–1066

  33. Wagner J (1975) Fundamentals of clinical pharmacokinetics. Chap. 11. Drug Intelligence Publications, Hamilton, Ill

  34. Welling PG, Huang H, Kock PA, Craig WA, Madsen PO (1977) Bioavailability of ampicillin and amoxycillin in fasted and non-fasted subjects. J Pharm Sci 66: 549–552

  35. Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390

  36. Ylitalo P, Hinkka H, Neuvonen PJ (1977) Effect of exercise on the serum level and urinary excretion of tetracycline, doxycycline and sulphamethizole. Eur J Clin Pharmacol 12: 367–373

  37. Zarowny D, Ogilvie R, Tamblyn D, Macleod C, Ruedy J (1974) Pharmacokinetics of amoxycillin. Clin Pharmacol Ther 16: 1045–1051

Download references

Author information

Correspondence to M. S. Roberts.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Roberts, M.S., Denton, M.J. Effect of posture and sleep on pharmacokinetics. Eur J Clin Pharmacol 18, 175–183 (1980). https://doi.org/10.1007/BF00561587

Download citation

Key words

  • amoxycillin
  • pharmacokinetics
  • bedrest
  • sleep
  • ambulation
  • renal clearance